A phase I trial of continuous infusion of the multidrug resistance inhibitor zosuquidar with daunorubicin and cytarabine in acute myeloid leukemia. [electronic resource]
Producer: 20090528Description: 1055-61 p. digitalISSN:- 1873-5835
- ATP Binding Cassette Transporter, Subfamily B, Member 1 -- antagonists & inhibitors
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Cytarabine -- administration & dosage
- Daunorubicin -- administration & dosage
- Dibenzocycloheptenes -- administration & dosage
- Drug Resistance, Multiple
- Drug Resistance, Neoplasm
- Female
- Humans
- Leukemia, Myeloid, Acute -- drug therapy
- Male
- Middle Aged
- Quinolines -- administration & dosage
- Time Factors
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.